Filing Details
- Accession Number:
- 0001179110-18-005850
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-04-24 21:06:22
- Reporting Period:
- 2018-04-20
- Accepted Time:
- 2018-04-24 21:06:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1034842 | Rigel Pharmaceuticals Inc | RIGL | Pharmaceutical Preparations (2834) | 943248524 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1419579 | Anne-Marie Duliege | Rigel Pharmaceuticals, Inc. 1180 Veterans Boulevard South San Francisco CA 94080 | Evp & Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-04-20 | 5,000 | $4.11 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 26, 2018.
- The Reporting Person purchased these shares on December 29, 2017 under the Employee Stock Purchase Plan.
Billionaire Hedge Funds
